Cargando…

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK

Mycobacterium tuberculosis, the etiological agent of the infectious disease tuberculosis, kills approximately 1.5 million people annually, while the spread of multidrug-resistant strains is of great global concern. Thus, continuous efforts to identify new antitubercular drugs as well as novel target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiarelli, Laurent R., Mori, Giorgia, Orena, Beatrice Silvia, Esposito, Marta, Lane, Thomas, de Jesus Lopes Ribeiro, Ana Luisa, Degiacomi, Giulia, Zemanová, Júlia, Szádocka, Sára, Huszár, Stanislav, Palčeková, Zuzana, Manfredi, Marcello, Gosetti, Fabio, Lelièvre, Joël, Ballell, Lluis, Kazakova, Elena, Makarov, Vadim, Marengo, Emilio, Mikusova, Katarina, Cole, Stewart T., Riccardi, Giovanna, Ekins, Sean, Pasca, Maria Rosalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816626/ https://www.ncbi.nlm.nih.gov/pubmed/29453370 http://dx.doi.org/10.1038/s41598-018-21614-4

Ejemplares similares

Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
por: Mori, Giorgia, et al.
Publicado: (2015)

Structural basis of reiterative transcription from the pyrG and pyrBI promoters by bacterial RNA polymerase
por: Shin, Yeonoh, et al.
Publicado: (2020)

A new vector for efficient gene targeting to the pyrG locus in Aspergillus niger
por: Arentshorst, Mark, et al.
Publicado: (2015)

Molecular characterization of the niaD and pyrG genes from Penicillium camemberti, and their use as transformation markers
por: Navarrete, Katherinne, et al.
Publicado: (2009)

Large-Scale Production of Anti-RNase A VHH Expressed in pyrG Auxotrophic Aspergillus oryzae
por: Karaman, Elif, et al.
Publicado: (2023)

Development of a pyrG Mutant of Aspergillus oryzae Strain S1 as a Host for the Production of Heterologous Proteins
por: Ling, Selina Oh Siew, et al.
Publicado: (2013)

Crizotinib Shows Antibacterial Activity against Gram-Positive Bacteria by Reducing ATP Production and Targeting the CTP Synthase PyrG
por: Zheng, Yun-Dan, et al.
Publicado: (2022)

The Cas9-gRNA ribonucleoprotein complex-mediated editing of pyrG in Ganoderma lucidum and unexpected insertion of contaminated DNA fragments
por: Eom, Hyerang, et al.
Publicado: (2023)

New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022)

Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
por: Mori, Giorgia, et al.
Publicado: (2020)

Molecular detection and pyrG sequence analysis of Avibacterium paragallinarum using clinical samples of infraorbital exudates from layer chickens with infectious coryza symptoms in Indonesia
por: Putra, Fadhli Nanda, et al.
Publicado: (2023)

Disruption or reduced expression of the orotidine-5′-decarboxylase gene pyrG increases citric acid production: a new discovery during recyclable genome editing in Aspergillus niger
por: Zhang, Lihui, et al.
Publicado: (2020)

Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019)

"Evaluación sensorial del producto arti-pank"
por: Peralta Palacios, Miriam
Publicado: (2007)

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis
por: Salina, Elena G., et al.
Publicado: (2022)

Novel PANK2 mutation in a Chinese boy with PANK2-associated neurodegeneration: A case report and review of Chinese cases
por: Zhang, Yingying, et al.
Publicado: (2019)

CanB, a Druggable Cellular Target in Mycobacterium tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2023)

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
por: Recchia, Deborah, et al.
Publicado: (2023)

PKAN neurodegeneration and residual PANK2 activities in patient erythrocytes
por: Werning, Maike, et al.
Publicado: (2020)

Generation and Validation of an Anti-Human PANK3 Mouse Monoclonal Antibody
por: Khadka, Sunada, et al.
Publicado: (2022)

The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021)

[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017)

MAS-NMR of [Pyr(13)][Tf(2)N] and [Pyr(16)][Tf(2)N] Ionic Liquids Confined to Carbon Black: Insights and Pitfalls
por: Merz, Steffen, et al.
Publicado: (2021)

Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration
por: Orellana, Daniel I, et al.
Publicado: (2016)

Molecular Mechanisms in the Activation of Abscisic Acid Receptor PYR1
por: Dorosh, Lyudmyla, et al.
Publicado: (2013)

CEPR2 phosphorylates and accelerates the degradation of PYR/PYLs in Arabidopsis
por: Yu, Zipeng, et al.
Publicado: (2019)

In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
por: Degiacomi, Giulia, et al.
Publicado: (2020)

A New Allelic Variant in the PANK2 Gene in a Patient with Incomplete HARP Syndrome
por: Martos, Myriam Ley, et al.
Publicado: (2020)

Novel PANK2 Mutations in Patients With Pantothenate Kinase-Associated Neurodegeneration and the Genotype–Phenotype Correlation
por: Li, Wen-Bin, et al.
Publicado: (2022)

The Role of ABA in Plant Immunity is Mediated through the PYR1 Receptor
por: García-Andrade, Javier, et al.
Publicado: (2020)

Identification of pyrC gene as an immunosuppressive factor in Francisella novicida infection
por: Nakamura, Takemasa, et al.
Publicado: (2022)

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
por: Stelitano, Giovanni, et al.
Publicado: (2020)

1-Sulfonyl-3-amino-1H-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
por: Kazakova, Elena, et al.
Publicado: (2023)

A Novel Nonsense Mutation in PANK2 Gene in Two Patients with Pantothenate Kinase-Associated Neurodegeneration
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2016)

Novel PANK2 mutation in the first Greek compound heterozygote patient with pantothenate-kinase-associated neurodegeneration
por: Paraskevas, George P, et al.
Publicado: (2017)

Comment on “A New Allelic Variant in the PANK2 Gene in a Patient with Incomplete HARP Syndrome”
por: Walker, Ruth Helen, et al.
Publicado: (2021)

Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2022)

PI3K-PANK4: a new target for de novo synthesis of coenzyme A
por: Guan, Jizhong, et al.
Publicado: (2022)

Structural Insights into the Abscisic Acid Stereospecificity by the ABA Receptors PYR/PYL/RCAR
por: Zhang, Xingliang, et al.
Publicado: (2013)

Structure determination and activity manipulation of the turfgrass ABA receptor FePYR1
por: Ren, Zhizhong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e98j9sp3hj9pmmaffhmmt5si43